CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 87 enrolled
Drug / intervention
standard PROMOS prosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02280499
NCT02280499N/ACompleted
CompareCT.gov

Multicenter Clinical Observation PROMOS®

Smith & Nephew Orthopaedics AG·observational·Posted Oct 31, 2014·Updated Mar 21, 2016

In Brief

An observational study evaluating standard PROMOS prosthesis for Primary and Secondary Omarthrosis. Completed, enrolled 87 participants.

Detailed Summary

Overall study design: This study is a prospective, multicenter, postmarket clinical observation to validate the PROMOS™ Standard Shoulder System as state-of-the-art implant system for total shoulder arthroplasty in terms of radiographic and clinical performance as well as long-term survivorship over 10 years.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary and Secondary Omarthrosis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 31, 2014
Enrollment StartNov 1, 2003
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 11.3 yearsPosted 11.7 years ago

Interventions

standard PROMOS prosthesisdevice